兰索拉唑、痢特灵、阿莫西林及果胶铋联合根治幽门螺杆菌阳性消化性溃疡的临床研究  

The clinical research of Lansoprazole,Furaxone,Amoxicillin and Pectin Bismuth in the eradicating treatment of patients with helicobacter pylori positive peptic ulcer

作　　者：何运梯 林玉如[1] 邬淑清 李敏英[1] 张建雯[1] 

机构地区：[1]广东省四会市人民医院急诊科,广东四会526200

出　　处：《中国医药导报》2010年第35期49-50,共2页China Medical Herald

摘　　要：目的:探讨兰索拉唑、痢特灵、阿莫西林及果胶铋联合根治幽门螺杆菌阳性消化性溃疡的临床效果。方法:选取我院幽门螺杆菌感染阳性消化性溃疡患者180例,将以上患者随机分为治疗组和对照组,治疗组采用兰索拉唑、阿莫西林、果胶铋及痢特灵四联疗法;对照组采用兰索拉唑、阿莫西林及果胶铋三联疗法。两组患者疗程均为2周。结果:两组患者幽门螺杆菌根除率比较,观察组总有效率为94.6%,差异有统计学意义(P<0.05);两组患者临床治疗效果比较,观察组总有效率为95.6%,差异有统计学意义(P<0.05)。结论:兰索拉唑、痢特灵、阿莫西林及果胶铋联合治疗幽门螺杆菌阳性消化性溃疡临床疗效显著,幽门螺杆菌根除率高,值得临床借鉴。Objective： To explore the clinical effect of Lansoprazole,Furaxone,Amoxicillin and Pectin Bismuth in the eradicating treatment of helicobacter pylori positive peptic ulcer.Methods： 180 patients with helicobacter pylori positive peptic ulcer were selected and randomly divided into treatment group and control group,the treatment group was given Lansoprazole,Furaxone,Amoxicillin and Pectin Bismuth,and the control group was given Lansoprazole,Amoxicillin and Pectin Bismuth.Two groups with a course for two weeks.Results： The comparison of two groups of helicobacter pylori eradication rates was statistically significant differences（P〈0.05）,the total rate of clinical efficacy of treatment was 94.6%;clinical effect of two groups had been compared（P〈0.05）,the the total rate of clinical efficacy of treatment was 95.6%.Conclusion： The treatment of Lansoprazole,Furaxone,Amoxicillin and Pectin Bismuth in helicobacter pylori positive peptic ulcer has obvious effect,the eradication of helicobacter pylori rate is high,it is worth using for reference.

关 键 词：幽门螺杆菌 消化性溃疡 痢特灵 兰索拉唑 阿莫西林 果胶铋 

分 类 号：R573.1[医药卫生—消化系统]